Showing 1 to 2 of 2 results


Lecanemab: EMA Approval and Limitations
EMA approves Lecanemab, a new Alzheimer's drug targeting amyloid plaques, but with limitations due to side effects and treatment complexity.
Lecanemab: EMA Approval and Limitations
EMA approves Lecanemab, a new Alzheimer's drug targeting amyloid plaques, but with limitations due to side effects and treatment complexity.
Progress
0% Bias Score

EU Parliament Postpones Vice-President Approvals Amid Political Wrangling
The European Parliament postponed the approval of six vice-presidents due to political maneuvering by the Spanish Popular Party against Teresa Ribera, causing tension and potential delays in forming the new European Commission.

EU Parliament Postpones Vice-President Approvals Amid Political Wrangling
The European Parliament postponed the approval of six vice-presidents due to political maneuvering by the Spanish Popular Party against Teresa Ribera, causing tension and potential delays in forming the new European Commission.
Progress
0% Bias Score
Showing 1 to 2 of 2 results